1706.7000 -27.10 (-1.56%)
NSE Jul 31, 2025 15:31 PM
Volume: 3.2M
 

Axis Direct
Sun Pharma: Dual play on US Recovery & growth in IPM, Resolution of Halol plant a key trigger; Godrej Consumer Products: Diverse Portfolio, focused on innovation, Dual play on Domestic and Emerging Markets
Sun Pharmaceutical I.. has an average target of 2105.29 from 7 brokers.
More from Sun Pharmaceutical Industries Ltd.
Recommended